TY - CHAP A1 - Bosco Paes A2 - Barry Rodgers-Gray A3 - Xavier Carbonell-Estrany ED1 - Bernhard Resch Y1 - 2019-10-30 PY - 2019 T1 - Resolving the Debate on RSV Prophylaxis in Late Preterm Infants N2 - Respiratory syncytial virus (RSV) causes seasonal epidemics during the winter and wet seasons, particularly in young children. Although there is one drug available for prophylaxis, palivizumab, it is indicated for high-risk children only. Therefore a vaccine is urgently needed. This book provides an overview of RSV and discusses its incidence and presentation in different populations, including preterm infants and children with congenital heart disease. It also discusses future strategies for RSV prophylaxis and developments in and barriers to creating a viable vaccine. BT - The Burden of Respiratory Syncytial Virus Infection in the Young SP - Ch. 2 UR - https://doi.org/10.5772/intechopen.85073 DO - 10.5772/intechopen.85073 SN - 978-1-78984-643-0 PB - IntechOpen CY - Rijeka Y2 - 2021-04-19 ER -